Flagship Pioneering Nurtures Unique Start-Ups Until They Can Take Wing
Executive Summary
Flagship Pioneering founder and CEO Noubar Afeyan says "watch this space" for another new start-up financing after Evelo Biosciences' successful $50m raising.
You may also be interested in...
Rubius Prepares Off-The-Shelf Red Cell Therapies For First Human Trial In 2018
Emerging Company Profile: Rubius Therapeutics is developing genetically engineered red blood cells and has raised $145m to take its first off-the-shelf, long-acting Red Cell Therapeutic into the clinic in 2018.
Finance Watch VC Edition: Biopharma Venture Investment Rises In Second Quarter
Venture capital investment in biopharmaceutical firms for the first half of 2017 show that this year is on track to exceed 2016 levels. Recent financings include two $50m Series C rounds for two different companies developing later-stage drugs for itching: Trevi and Menlo Therapeutics.
Flagship Ventures Tempts Former Merck CMO With 'Creative' Mentoring Role
Flagship Ventures has recruited former Merck Chief Medical Officer Michael Rosenblatt as its CMO to mentor biopharma startups in the venture firm's portfolio – a hire that appears to be the first of its kind.